New Cardiovascular Risk Screening Strategy.

NARecruitingINTERVENTIONAL
Enrollment

54,000

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Cardiovascular PreventionScreeningPeripheral Artery DiseaseArteriosclerosisAsymptomatic
Interventions
DIAGNOSTIC_TEST

HELENA

"The current CV risk screening program in based using the REGICOR risk function, which is integrated in the primary care electronic health record. This risk function predicts the probability within 10 years of developing a coronary event. Those who are categorized as high risk, obtaining a 10% of probability, are candidates of receiving lipid lowering drugs and recommendations on healthy life habits.~What this intervention suggests is that, besides the REGICOR estimation, the electronic health records will also incorporate a new CV risk function, REASON. The model predicts the risk of holding a pathologic ABI score, in people aged 50-74 years old who are apparently free of CV. Patients who obtain a score ≥ 7 will undergo a PAD screening program with ABI test. If the value of the test is ≤0.9, the REGICOR, physicians will recommend indications of the Health Catalan Institute's CV and lipid Guidelines to the patients."

Trial Locations (1)

08007

RECRUITING

Institut Català de la Salut (ICS), Barcelona

All Listed Sponsors
collaborator

Hospital del Mar Research Institute (IMIM)

OTHER

collaborator

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

OTHER

collaborator

Institut Català de la Salut

OTHER

collaborator

Biocruces Bizkaia Health Research Institute

OTHER_GOV

lead

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER